Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
eNews June 2012
Will teriflunomide by the next MS pill?

Positive results seen in third trial of drug

In a clinical trial involving 1,169 people with relapsing-remitting MS, oral teriflunomide (Genzyme/Sanofi-Aventis) reduced relapses compared with placebo according to a recent company press release. An application for marketing approval of teriflunomide was accepted for review by the FDA in October.

Read more about the study

 Donate Now

 Find us on Facebook 

twitter  youtube  flickr  linkedin  MSConnection.org



Caterina Fedyk and 14 other Top Society Scholars



Connect with people and information that move lives forward

Everyday MattersWhat do YOU need to make every day matter?

Everyday Matters will highlight five inspiring stories of people affected by MS, each focused on something that we all strive to enhance every day. Join the journey for resources and ideas — first by voting on the topic that most impacts your everyday life. Everyday Matters is supported by Genzyme.

Vote now


Community chat Do you have questions about progressive MS?

Join us Monday, June 18, 2012 at 4:00 pm ET for a live community chat focusing on progressive MS. Society Chief Research Officer, Tim Coetzee, and Peter Calabresi, MD, will be live in the MS Connection community.

Ask your question now and check back on
June 18 to view responses from the experts.

More MS News 

June 12: Genzyme applies to FDA for approval of alemtuzumab to treat relapsing MS

May 30: Survey of MS specialists suggests people commonly misdiagnosed as having MS

Read more about these and other recent reports

This communication is partially sponsored through the generous support of
Biogen Idec; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.

MS Active Source Novartis
Join a Walk MS Event       Join a Bike MS Event      Shop at the Society Store

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our website.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to   .
To ensure that you continue to receive our emails, please add us to your address book.